SBC Medical Shares Fall 19.5% on Offering

SBC Medical Group stock plunged 19.5% after pricing a secondary public offering of 3.1 million shares at $3.25 each.
The selling shareholder, Dr. Yoshiyuki Aikawa, will receive all proceeds; SBC will not receive any funds from the transaction.
Underwriters have a 45‑day option for an extra 465,000 shares; Maxim Group LLC leads book‑running with Roth Capital as co‑manager.
The offering is slated to close around April 21, 2026; the company listed on Nasdaq in Sep 2024 and joined Russell 3000 in Jun 2025.